By adding a new category to lung CT reports, radiologists can identify more malignant lesions.
Adding a new 4X assessment category in lung CT screening reports for lesions suspicious for malignancies allows experienced radiologists to detect more malignancies, according to a study published in the journal Radiology. Using the National Lung Cancer Trial database, researchers from the Netherlands, Korea, Italy, and Austria sought to determine the added value of Lung CT Screening Reporting and Data System (Lung-RADS) assessment category 4X over categories 3, 4A, and 4B for differentiating between benign and malignant sub-solid nodules (SSNs). 4X was a recently introduced category. The researchers searched for baseline CT scans that were classified as Lung-RADS category 3 or higher. They identified 374 SSNs for analysis. One experienced screening radiologist volumetrically segmented all solid cores and located all malignant SSNs visible on baseline scans. Six experienced chest radiologists independently determined which nodules to upgrade to category 4X, and they compared malignancy rates of purely size-based categories and category 4X. The researchers also calculated false-positive rates of category 4X lesions. The results showed that 15 percent to 24 percent of the SSNs were upgraded to category 4X. The malignancy rate for 4X nodules varied from 46 percent to 57 percent per observer and was substantially higher than the malignancy rates of categories 3, 4A, and 4B SSNs without observer intervention (9 percent, 19 percent, and 23 percent, respectively). The false-positive rate for category 4X nodules was an average of 7 percent for category 3 SSNs, 7 percent for category 4A SSNs, and 19 percent for category 4B SSNs. Of the falsely upgraded benign lesions, on average 27 percent were transient. The agreement among the observers was moderate. The researchers concluded experienced radiologists can find more malignancies with a new 4X assessment category in a nodule management tool. Proof of the transient character of category 4X lesions at short-term follow-up could avoid unnecessary invasive management.
Multicenter CT Study Shows Benefits of Emerging Diagnostic Model for Clear Cell Renal Cell Carcinoma
May 15th 2024Combining clinical and CT features, adjunctive use of a classification and regression tree (CART) diagnostic model demonstrated AUCs for detecting clear cell renal cell carcinoma (ccRCC) that were 15 to 22 percent higher than unassisted radiologist assessments.
What a New Meta-Analysis Reveals About Fractional Flow Reserve Assessment with Computed Tomography
May 13th 2024While acknowledging variable accuracy overall with CT-derived fractional flow reserve (FFR-CT) values, researchers found that the accuracy rate increased to 90 percent for FFR-CT values greater > 0.90 and < 0.49.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds High Concordance Between AI and Radiologists for Cervical Spine Fractures on CT
May 6th 2024Researchers found a 98.3 percent concordance between attending radiology reports and AI assessments for possible cervical spine fractures on CT, according to new research presented at the 2024 ARRS Annual Meeting.
FDA Clears AI-Powered Qualitative Perfusion Mapping for Cone-Beam CT
May 6th 2024Reportedly validated in more than 10 clinical trials, the AngioFlow perfusion imaging software enables timely identification of brain regions with cerebral blood flow reduction and those with significant hypoperfusion.